Vorasidenib is a new medication, and is being used at a place in therapy where previously there were no available treatment options.

Similarly, the inVolve program is very new and currently offering only basic information. The growth of this portal will be directed by you and others taking vorasidenib across Australia and New Zealand.

If you would like to provide your feedback, become involved with patient advisory initiatives or share your story with others on the inVolve platform, we welcome you to reach out to us through the form below.